Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis

BACKGROUND AND PURPOSE: The considerable clinical effect of natalizumab in patients with relapsing-remitting multiple sclerosis might be explained by its possible beneficial effect on axonal functioning. In this longitudinal study, the effect of natalizumab on absolute concentrations of total N-acet...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AJNR Am J Neuroradiol
Main Authors: Wiebenga, O.T., Klauser, A.M., Schoonheim, M.M., Nagtegaal, G.J.A., Steenwijk, M.D., van Rossum, J.A., Polman, C.H., Barkhof, F., Pouwels, P.J.W., Geurts, J.J.G.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Neuroradiology 2015
Assuntos:
Brain
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8013024/
https://ncbi.nlm.nih.gov/pubmed/25742985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A4252
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados